Multiplan Corporation Stock Plummeting Despite Wall Street Analyst’s ‘Hold’ Rating
June 21, 2023
🌥️Trending News
Multiplan Corporation ($NYSE:MPLN), a leading provider of technology-enabled healthcare cost management services, has experienced a tumultuous time on the stock market in the past year. The company’s stock has plummeted by -68.86%, much to the surprise of many Wall Street analysts who had given it an average rating of Hold. Despite the downward trend, analysts are still recommending that investors hold onto their shares. Analysts suggest that the stock has been undervalued for some time and that it could be a good long-term investment. As the company continues to expand its services in the healthcare industry, its stock could experience a drastic rebound. Multiplan Corporation has a strong presence in the U.S., Brazil, and Canada, and it is growing rapidly in other markets.
The company is well-positioned to benefit from the ongoing trend of healthcare cost reduction and improved efficiency throughout the industry. Multiplan Corporation has made a number of strategic acquisitions in the last few years, and its strategic partnerships with leading health systems and payers have enabled it to offer innovative solutions to its clients. The company’s performance has been further bolstered by its products and services that manage costs associated with medical services and drug prices. As a result, analysts are hopeful that the stock will experience a resurgence in the near future.
Market Price
On Tuesday, Multiplan Corporation stock opened at $1.6 and closed at $1.8, a 7.2% increase from the last closing price of $1.7. Despite Wall Street analyst’s ‘Hold’ rating, the company’s stock appears to be plummeting. Analysts remain uncertain about the company’s future prospects, citing concerns over its business model and competitive landscape.
While some investors are optimistic about the long-term potential of Multiplan Corporation, others remain skeptical and are unwilling to hold onto the stock in the short-term. The company has yet to present a cohesive strategy for tackling the challenges it faces, leading to further anxiety among investors. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Multiplan Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 1.02k | -616.68 | -4.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Multiplan Corporation. More…
| Operations | Investing | Financing |
| 241.64 | -103.38 | -219.91 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Multiplan Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 7.22k | 5.43k | 2.8 |
Key Ratios Snapshot
Some of the financial key ratios for Multiplan Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 3.2% | -3.2% | -29.6% |
| FCF Margin | ROE | ROA |
| 15.1% | -10.5% | -2.6% |
Analysis
At GoodWhale, we’ve done a thorough analysis of MULTIPLAN CORPORATION’s financials and rate them as medium risk in terms of financial and business aspects. We advise potential investors to pay close attention to any changes in these aspects as they could drastically alter the risk rating. In addition, our analysis has detected one risk warning within the balance sheet. To get an in-depth evaluation of this warning, become a registered user on GoodWhale. By signing up, you’ll gain access to our comprehensive reports which provide details on this and other related risks. More…
Peers
Its competitors include MobileSmith Inc, Beijing Airdoc Technology Co Ltd, and Phreesia Inc.
– MobileSmith Inc ($SEHK:02251)
Beijing Airdoc Technology Co Ltd is a Chinese company that specializes in the development of software for the aviation industry. The company has a market capitalization of 1.1 billion as of 2022 and a return on equity of -7.19%. Despite its negative ROE, the company’s market cap indicates that investors believe it has significant potential. The company’s products are used by major airlines around the world, and it is continuing to invest in research and development in order to maintain its competitive edge.
– Beijing Airdoc Technology Co Ltd ($NYSE:PHR)
Phreesia Inc is a healthcare technology company that provides patient intake and engagement solutions. The company has a market cap of 1.29B as of 2022 and a Return on Equity of -30.7%. Phreesia’s solutions are used by healthcare organizations to manage patient data, reduce operational costs, and improve patient engagement.
Summary
Multiplan Corporation is a publically traded company that has been in the stock market for the past 12 months. Over this time period, the stock has seen a sharp decline of -68.86%. The average rating from Wall Street analysts is a Hold, meaning that there is little optimism for the company’s future performance. Despite this, stock prices have seen a slight bump in recent days.
When investing in Multiplan Corporation, it is important to consider the current market conditions and any other external factors that may be affecting performance before making a decision. It is also important to research the company’s financials and management to determine if any risks may be present. Ultimately, investors should use caution and make sure to weigh all available information before making any decisions about investing in the company.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
